CERUS CORP — Director's Dealing 2017

Mar 4, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CERUS CORP (CERS)
CIK: 0001020214
Period of Report: 2017-03-01

Reporting Person: Benjamin Richard J (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-03-01	Option (Right to Buy)	$4.33	A	100000	Acquired	2027-02-28	Common Stock (100000)	Direct
2017-03-01	Restricted Stock Unit	$	A	22500	Acquired		Common Stock (22500)	Direct

Footnotes

F1: One eighth (1/8th) of the shares subject to the Option shall vest six (6) months after the transaction date and one forty-eighth (1/48th) of the shares subject to the Option shall vest on each monthly anniversary of the transaction date thereafter.

F2: Not applicable.

F3: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.

F4: The restricted stock unit vests in three equal annual installments beginning on March 12, 2018.